‘Tour de force’ by Chinese chemists could overturn high cost of drug treatments

南华早报
2025.11.10 04:00
portai
I'm PortAI, I can summarize articles.

Chinese chemists have made a significant breakthrough in drug production, solving a 140-year-old chemistry problem that could reduce the cost of cancer treatments and other medicinal compounds. Co-led by Zhang Xiaheng and Xue Xiaosong, the research proposes a safer and more affordable method using nitro groups instead of traditional diazonium salts. The new approach has shown success rates of 46 to 90% in converting raw materials into desired products, and the team is collaborating with local pharmaceutical companies to implement this technology, which may lead to more affordable treatments for the masses.

Scientists in China have solved a 140-year-old chemistry problem in a breakthrough that could overturn traditional production methods and slash the cost of cancer treatments and other expensive medicinal compounds.\nThe research was co-led by Zhang Xiaheng, from the Chinese Academy of Sciences’ Hangzhou Institute for Advanced Study, and Xue Xiaosong, a professor with the Shanghai Institute of Organic Chemistry, and published in the peer-reviewed journal Nature.\nIn his review of the paper, Scott Bagley, a senior principal scientist at Pfizer, described it as a “tour de force”, while some within China’s chemical research community are rating the team’s feat as “Nobel Prize level”.\nThe researchers proposed a straightforward alternative to the expensive, complex and dangerous method used by the chemical industry for more than a century to synthesise drugs and pesticides from a class of organic compounds called amines.\nAccording to the paper, the team’s approach overcomes the many issues that have plagued the classical method – including the risk of explosions – and holds promise for making the production of important chemicals safer and more affordable.\n“Overall, the authors have delivered a true tour de force here, not just developing the method but doing extensive scope, in-depth mechanistic studies and synthetic applications that clearly demonstrate the capabilities of this chemistry to be useful in many contexts,” Bagley said.\nCorresponding author Zhang said in an interview with Chemical & Engineering News that he thought industrial people would “really, really benefit” from the chemistry detailed in the paper.\nTraditionally, chemists have relied on diazonium salts as intermediates to transform inexpensive aromatic amines into highly valuable raw materials in a process called the Sandmeyer reaction.\n\n\nBy leveraging their high reactivity, the chemical industry has been able to use these organic compounds as building blocks for the complex molecules that are indispensable in fields ranging from pesticides and pharmaceuticals to dyes and textiles.\nHowever, this standard method – proposed in 1884 by the Swiss chemist Traugott Sandmeyer – has a notorious downside. It poses significant safety risks because of the explosive and unstable nature of the salts.\nAccording to the local bureau of science and technology in the eastern city of Hangzhou, Zhang’s team spent three years exploring direct transformation pathways for aromatic amines.\nTheir innovative solution uses nitro groups instead of diazoniums and does not require an expensive metal catalyst or multiple steps, the bureau said in an article about the breakthrough.\nThe core advantage of the research team’s “one-pot” strategy lies in its remarkable versatility, achieved using only simple, readily available reagents, it said.\nThe researchers tested more than 170 chemical raw materials, including structurally complex drug molecules such as antiviral treatments.\n\n\n\n\nThe new method efficiently converted the raw materials into the desired products, with success rates ranging from 46 to 83 per cent, the researchers reported. Traditional methods were largely ineffective in such cases, they said.\nThe team also conducted a kilogram scale trial to show the new approach’s potential in a real-world setting. These tests achieved a success rate of up to 90 per cent, according to the study.\nZhang and his colleagues have reportedly begun working with local pharmaceutical and chemical companies to explore how the breakthrough could help to address their industrial needs.\nMeanwhile, on Chinese social media, the team’s achievement is being hailed by some commenters from the chemical research community as worthy of a Nobel Prize.\nLife Sciences Frontier, a specialist social media account, said that production costs were expected to decrease significantly once the technology was incorporated into the manufacturing processes of generic, hi-tech anticancer drugs, making them “more affordable for the masses”.\nPassionate about science? Dive deeper with the Dark Matters newsletter, a weekly in-depth analysis on China’s rise in science, technology and military that goes beneath the surface. Sign up for free now.\n